Cannabis Law Report

JUNE 16, 2021

This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol. This relationship enables us to initiate our clinical research program and marks an important step for Wake in Canada.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Veriheal

AUGUST 31, 2020

Program between St. About Sinibaldo: Sinibaldo is an aspiring healthcare professional and a biomedical researcher in the Medical Scientist Training Program (M.D./Ph.D.) About Nishtha: Nishtha is pursuing neurology to become a physician-scientist in honor of her grandmother Nani who suffered from Alzheimer’s.

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

JANUARY 6, 2022

Oregon’s developing psilocybin program is nothing short of revolutionary and provides an opportunity to investigate the potential of psilocybin in treating a myriad of mental health conditions. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products. By Brett Mulligan.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

AUGUST 29, 2021

Aureus branded products are cultivated, extracted, and manufactured by Avicanna ’s subsidiaries in Colombia where they benefit from optimal environmental conditions to produce cannabinoid active pharmaceutical ingredients economically and sustainably and include a range of extracts of CBD, THC and rare cannabinoids such as CBG.

Extraction 98

Extraction Supply Chain Research and Development CBD 98

SpeedWeed

AUGUST 11, 2021

The grant comes from Michigan’s 2021 Veteran Marijuana Research Grant Program , and is funded by the state’s recreational cannabis taxes. With a goal of determining the “the efficacy of marijuana in treating the medical conditions of United States armed services veterans and preventing veteran suicide.”. MAPS Makes History.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

MMJ Recs

FEBRUARY 8, 2021

This has given residents of the state access to the relief that MMJ can provide for a plethora of different conditions. There is a New York State Prescription Monitoring Program (PMP) that compiles data from all patients so that doctors can review each patient’s history thoroughly and make a treatment plan and amount on a case-by-case basis.

Legalization 52

Legalization Edibles Patients Treatment 52

Cannabis Law Report

JUNE 7, 2021

NASDAQ: APDN) (Applied DNA or the “Company”), a leader in Polymerase Chain Reaction (PCR)-based DNA manufacturing, and its program development partner, Evvivax, S.R.L. 1.526 were reduced as expected and consistent with other CDC-reported data on vaccine-induced antibody neutralization against these variants 1. P1 (Brazil), and B.1.526

Clinical Trials 64

Clinical Trials Research and Development Therapy Supply Chain 64

WeedAdvisor

SEPTEMBER 26, 2019

As Illinois prepares to follow through with their recreational marijuana rollout, Marijuana Business Daily reports the state’s biggest increase in medical cannabis sales throughout the program’s history. The patient count also includes 2,500 people who are enrolled in the state’s new opioid alternative pilot program.

Recreational 45

Recreational Patients Programs History 45

Cannabis Law Report

JULY 29, 2021

Aureus branded products are cultivated, extracted, and manufactured by Avicanna’s subsidiaries in Colombia where they benefit from optimal environmental conditions to produce cannabinoid active pharmaceutical ingredients economically and sustainably and include a range of extracts of CBD, THC and rare cannabinoids such as CBG.

Extraction 98

Extraction Supply Chain THC Research and Development 98

Cannabis Law Report

AUGUST 11, 2021

Under the Licensing Agreement, which has an initial three-year term, Avicanna has exclusively licensed, subject to certain conditions and exceptions, the use of certain proprietary product formulations to Heritage to be marketed and sold under Heritage’s medical Opticann branded products in non-competing medical channels in Canada.

Topical 98

Topical Research and Development Seed-To-Sale Pharmaceutical 98

Cannabis Law Report

FEBRUARY 17, 2020

For those of you in the dark about Florida’s Medical Marijuana Program, I will be lighting up the dim corners of Florida: The Nation’s Fastest-Growing Medical Marijuana Market , according to The Miami New Times on May 2, 2019. On the popular MarijuanaDoctors.com , all qualifying conditions in Florida are noted.

Dispensary 76

Dispensary Patients Agriculture Conditions 76

Cannabis Law Report

DECEMBER 16, 2021

Because recreational use of marijuana is increasing, especially as more states legalize it, the CDC believes it’s important for all workplaces to implement and address marijuana policies in their motor vehicle safety programs. This program gives New Mexico an edge in the growth of cannabis infrastructure.

Cannabinoids 52

Cannabinoids Retail Policy Cultivation 52

Cannabis Law Report

JUNE 1, 2021

“Our cost savings program is on track to deliver $150 – $200 million of savings within the next 18 months, and we remain committed to our path to profitability by the end of Fiscal 2022, while continuing to invest in an organization that is focused on insights, innovation and gaining momentum in the U.S. Net revenue.

Data 95

Data Vaping Supply Chain Business 95

Cannabis Law Report

NOVEMBER 29, 2021

The social and economic conditions of people’s lives influence the risks of drug use, i.e., conditions that can be improved by policies that promote racial, economic, and social justice. Make data about drug war enforcement publicly available and easily accessible, and regularly publish racial and gender impact analyses.

Policy 52

Policy Decriminalization Treatment History 52

Cannabis Law Report

APRIL 14, 2022

Accordingly, state pesticide programs have tried to provide some clarity to fill the gap left by EPA. pursuant to Drug Enforcement Agency (DEA) or state-level programs). Grow operations generate agricultural waste that must be managed and disposed of as a regulated or scheduled substance (e.g., million cars on the road.

Environment 52

Environment Agriculture Compliance Compliance 52

Cannabis Law Report

JULY 30, 2019

In my estimation, the state’s overall program growth in Florida to date is impressive. The ASA highlights that it takes the FDA “an average of 9 years to approve any drug, but it only takes approximately two to four weeks for a medical cannabis patient with chronic pain to be approved by a state program.”

Marijuana 40

Marijuana Education Patients Research and Development 40

CannaTech

OCTOBER 14, 2018

California Hemp History. The state was well-positioned to permit this type of farming back in 2013 when Senate Bill 566 was enacted, conditionally approving an industrial hemp pilot program. billion by 2022, according to New Frontier Data, a premier cannabis data analytics firm. In the U.S.

Hemp 53

Hemp Research and Development Agriculture Seed-To-Sale 53

Cannabis Law Report

NOVEMBER 9, 2021

Established history of providing FDA-approved ketamine infusion services: The management team at KWC has been in business for 6 years expanding services throughout the United States. Delic has been focused on opening locations in secondary cities with considerable demand, in an effort to provide access to the most patients.

Treatment 52

Treatment Therapy Media Access 52

Greenspoon Marder Cannabis Law Group Blog

JULY 18, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 2.

Law 40

Law Marijuana Education Safety 40

Cannabis Law Report

JANUARY 31, 2019

Now we find ourselves at a crossroads where our state’s history with marijuana and the future of cannabis commercialization meet. Greater acceptance of cannabis occurred in 1998 when Oregon, following California’s lead two years earlier, established a medical marijuana program.

Legislation 61

Legislation Recreational Marijuana Policy 61

Cannabis Law Report

JULY 20, 2019

New Jersey recently responded to public demand to revise and expand its medical marijuana program to address issues such as supply scarcity, employment and hiring concerns, and geographic access problems. History of compliance with regulations and policies governing government regulated marijuana programs. Criterion 2.

Law 40

Law Marijuana Education Cultivation 40

Cannabis Law Report

NOVEMBER 15, 2021

CRO orders typically provide a means to evaluate LinearDNA within a customer’s preclinical development program. Hurry, 917-733-5573, sanjay.hurry@adnas.com Program Manager: Brian Viscount, 631-240-8877, brian.viscount@adnas.com Web: www.adnas.com Twitter: @APDN. Investor Contact: Sanjay M.

Research and Development 52

Research and Development Therapy Clinical Trials Supply Chain 52

Cannabis Law Report

NOVEMBER 9, 2021

Hurry, 917-733-5573, sanjay.hurry@adnas.com Program Manager: Brian Viscount, 631-240-8877, brian.viscount@adnas.com Web: www.adnas.com Twitter: @APDN. For Applied DNA: Investor Contact: Sanjay M.

Clinical Trials 52

Clinical Trials Research and Development Therapy Supply Chain 52

Cannabis Law Report

JANUARY 4, 2022

Assay”) as a Laboratory Developed Test (LDT), pending a final review of the assay’s validation data by NYSDOH. With the conditional approval, ADCL can immediately employ the Linea 2.0 With the conditional approval, ADCL can immediately employ the Linea 2.0 Assay (the “Linea 2.0 The Linea 2.0 The Linea 2.0 Dr. James A.

Conditions 52

Conditions Research and Development Therapy Supply Chain 52

Cannabis Law Report

OCTOBER 12, 2021

I have a long history working in similar environments in the cannabis and the spirits industry during my time with Aphria (now Tilray) and Diageo. He has an extensive history in executive leadership and governance roles of large, diverse organizations.

Extraction 52

Extraction Business Hash Events 52

The Cannigma

AUGUST 5, 2022

Most existing research does not support the use of THC in combating depression and there is very limited data for other cannabinoids.” Nue Life is a telemedicine company that provides ketamine experiences for people with treatment-resistant depression and other mental health conditions. Who could you be if you felt better?

Treatment 138

Treatment Research and Development Therapy Digestion 138

Cannabis Law Report

AUGUST 12, 2019

Since M&A activity in the cannabis business is relatively new, note that your M&A advisor may have to triangulate deals done in closely related industries until the valuation data builds up. Make no mistake, the acquirer’s analysts will spare little expense to precisely determine those prospects.

Business 40

Business Banking Cannabis Concentrates 40

The Cannigma

MARCH 29, 2021

A 1988 trial found that women given very low-THC (1.8%) joints showed “statically significant increases in pulse rate,” and this increase was more pronounced and lasted longer for participants with a past history of intermittent marijuana use 5. Cardiac-related mortality data from the U.S. Is cannabis dangerous for the heart?

Blood Pressure 143

Blood Pressure Indica THC Strains 143

Cannabis Law Report

DECEMBER 7, 2021

Derived from the iboga shrub native to West Africa, it has a history as a spiritual sacrament in the Bwiti religion in the country of Gabon. A lab contracted by Nida’s Addiction Treatment Discovery Program will conduct preclinical tests on Delix’s compound to evaluate its pharmacological, pharmacokinetic and toxicological properties.

Treatment 52

Treatment Clinical Trials Data Conditions 52

Cannabis Law Report

MARCH 29, 2020

Won retail and processing licenses in Utah and received Clinical Registrant Designation by the Pennsylvania Department of Heath permitting Curaleaf to open a cultivation and processing facility and up to six dispensaries under the Commonwealth’s medical marijuana research program.

Dispensary 59

Dispensary Research and Development Retail Cultivation 59

Cannabis Law Report

DECEMBER 15, 2021

In 2021, atai has achieved many major milestones, for example the promising phase 2a data for its schizophrenia drug RL-007 or the Phase 2b readout of Compass Pathways , of which atai owns 22.6% And I’m not talking about additional business development opportunities but just the existing drug development programs.

Research and Development 52

Research and Development Data History Patients 52

Cannabis Law Report

AUGUST 6, 2021

1 Unless otherwise indicated, market share data disclosed in this press release is calculated using the Company’s internal proprietary market share tool that utilizes point of sales data supplied by a third-party data provider, government agencies and our own retail store operations across the country.

Vaping 105

Vaping Research and Development Data Business 105

Cannabis Law Report

NOVEMBER 9, 2021

On the top-line, we outperformed Headset industry data in the majority of our markets, and we generated positive retail adjusted EBITDA for the fifth consecutive quarter. MedMen Buds, the Company’s loyalty program, provides exclusive access to promotions, product drops and content. Learn more about MedMen at www.medmen.com.

Retail 52

Retail Events Cultivation Business 52

Cannabis Law Report

JANUARY 21, 2022

ADCL’s safeCircle program is a fully integrated testing platform for enterprise and educational institutions that provides a full range of COVID-19 diagnostic testing and associated services, including sample collection, test site infrastructure design and management, results tracking, and vaccination status management. The Linea 2.0

Collective 52

Collective Therapy Research and Development Supply Chain 52

The Cannigma

APRIL 8, 2021

We’ve actually had one or maybe even two cannabis pharmacists on this program before. The doctor diagnoses the condition and chooses a specific medicine. CP: I’m going to say yes and it’s hard to tie this together, but there’s actually some really good animal, and a little bit of human data to support this.

Medicine 108

Medicine Cannabinoids Cannabis THC 108

Cannabis Law Report

NOVEMBER 26, 2021

With the anticipated launch of Pfizer’s oral COVID-19 antiviral drug candidate, Can-Fite has made a strategic decision to end its COVID-19 program and to focus its resources on its other clinical programs, all in advanced clinical trials. dollars in thousands (except for share and per share data). . . Fortified Balance Sheet.

Clinical Trials 52

Clinical Trials Research and Development Treatment Data 52

SMPL

MAY 26, 2020

“There was a strong sense that this was really going to be something, if when people use these strains they have any kind of experience like the mice did in the laboratories,” said Martin Lee, a writer who at the time had been finishing a book about the social history of marijuana for Simon & Schuster. They saw the winds were shifting.”.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40